NCT05270707View on ClinicalTrials.gov

HyperArc Registry Study

CompletedOBSERVATIONAL
Enrollment

968

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Brain MetastasesCNS NeoplasmCNS Disorder, Intracranial
Interventions
RADIATION

Stereotactic radiosurgery

HyperArc is a radiotherapy treatment with a structured workflow to plan and deliver stereotactic radiosurgery (SRS).

Trial Locations (7)

2617

Icon Cancer Centre Canberra, Bruce

3000

University Hospital Leuven, Leuven

4120

Icon Cancer Centre Greenslopes, Greenslopes

4215

Icon Cancer Centre Gold Coast Private, Southport

4558

Icon Cancer Centre Maroochydore, Maroochydore

35233

University of Alabama, Birmingham

37024

L'IRCCS Ospedale Sacro Cuore - Don Calabria, Negrar

All Listed Sponsors
lead

Varian, a Siemens Healthineers Company

INDUSTRY